Arecor Therapeutics (AREC) News Today GBX 40 0.00 (0.00%) As of 04:50 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Arecor Therapeutics Full Year 2024 Earnings: Misses ExpectationsApril 23, 2025 | finance.yahoo.comArecor Therapeutics strikes deal for development of peptide therapyMarch 12, 2025 | lse.co.ukArecor Partners to Innovate Peptide Therapy FormulationMarch 12, 2025 | tipranks.comArecor Full Year 2024 Trading UpdateFebruary 4, 2025 | lse.co.ukArecor Therapeutics confident for the future as revenue risesFebruary 3, 2025 | lse.co.ukArecor Therapeutics Shifts Strategy, Ceases Tetris Pharma OperationsJanuary 10, 2025 | tipranks.comMARKET REPORT: British blue chips set to end the year on a whimperDecember 31, 2024 | msn.comArecor inks licensing deal for AT351December 30, 2024 | uk.investing.comArecor Therapeutics Appoints New Interim CFO David EllamNovember 18, 2024 | msn.comArecor Therapeutics First Half 2024 Earnings: UK£0.15 loss per share (vs UK£0.15 loss in 1H 2023)September 28, 2024 | finance.yahoo.comEARNINGS: Hansard Global profit down; Flowtech cuts outlookSeptember 27, 2024 | lse.co.ukAt278 Ultra-Concentrated Ultra-Rapid Acting Insulin Demonstrates Superiority in Phase i Clinical Trial in Overweight and Obese People With Type 2 DiabetesMay 20, 2024 | finance.yahoo.comArecor Therapeutics collaborates with Medtronic on novel insulinMay 9, 2024 | lse.co.ukArecor Therapeutics plc: Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump deliveryMay 9, 2024 | finanznachrichten.deArecor chief financial officer to leave in July after five yearsApril 23, 2024 | lse.co.ukArecor Therapeutics PLC Ordinary Shares ARECApril 18, 2024 | morningstar.comStrip Tinning shares up as hails "largest ever" glazing orderApril 2, 2024 | lse.co.ukArecor Therapeutics announces collaboration on oral GLP-1 drug for diabetes and obesity treatmentMarch 14, 2024 | finance.yahoo.comArecor to develop "holy grail" diabetes treatment with partner TRxMarch 12, 2024 | lse.co.ukARECOR AND TRx BIOSCIENCES ESTABLISH RESEARCH COLLABORATION TO DEVELOP ORAL GLP-1 WITH ENHANCED BIOAVAILABILITYMarch 12, 2024 | finance.yahoo.comArecor Therapeutics plc (AREC.L)February 16, 2024 | finance.yahoo.comArecor Therapeutics hails Arestat as 2023 performance "strong"February 1, 2024 | lse.co.ukArecor Therapeutics PLC Ordinary SharesJanuary 20, 2024 | morningstar.comTRADING UPDATES: Patent boosts for DG Innovate and Arecor TherapeuticsJanuary 18, 2024 | lse.co.ukArecor inks co-development deal with global medical companyDecember 4, 2023 | lse.co.ukArecor Therapeutics takes major step with first commercial sale of AT220November 17, 2023 | finance.yahoo.comTRADING UPDATES: Troy Income suspends buyback of sharesNovember 2, 2023 | lse.co.ukArecor Therapeutics subsidiary Tetris Pharma signs deal with GoodlifeSeptember 4, 2023 | lse.co.ukArecor Therapeutics to collaborate with "top 10" pharmaceutical firmAugust 17, 2023 | lse.co.ukArecor Therapeutics Flags Strong 1H ProgressJuly 20, 2023 | marketwatch.comArecor: Business UpdateJuly 20, 2023 | finance.yahoo.comShareholders in Arecor Therapeutics (LON:AREC) are in the red if they invested a year agoJune 3, 2023 | finance.yahoo.comArecor Therapeutics has "a strong basis to accelerate" growth strategyApril 24, 2023 | finance.yahoo.comRecent uptick might appease Arecor Therapeutics plc (LON:AREC) institutional owners after losing 16% over the past yearMarch 14, 2023 | finance.yahoo.comArecor to launch second Phase I clinical trial of AT278 rapid-acting insulin for diabetes patientDecember 1, 2022 | msn.comEven after rising 12% this past week, Arecor Therapeutics (LON:AREC) shareholders are still down 43% over the past yearNovember 10, 2022 | finance.yahoo.comTetris Pharma Launches Ogluo® in GermanyNovember 1, 2022 | finance.yahoo.comHeadline results from Phase I clinical trial of ultra-rapid acting insulin candidate AT247 demonstrate significantly accelerated insulin absorption and early exposure compared to gold standard insulins NovoLog® and Fiasp®October 11, 2022 | finance.yahoo.comArecor Therapeutics PLC (AREC)August 24, 2022 | investing.comIrish industrial output rises 8.5% in June from May, up 26% annuallyAugust 9, 2022 | lse.co.ukArecor Therapeutics to Raise GBP6 Mln Via Discounted Placing to Buy Tetris PharmaAugust 2, 2022 | marketwatch.comCompanies Like Arecor Therapeutics (LON:AREC) Are In A Position To Invest In GrowthJuly 18, 2022 | finance.yahoo.comArecor Therapeutics Says Future Revenue-Generating Collaboration Pipeline StrongJuly 16, 2022 | marketwatch.comArecor Therapeutics' (LON:AREC) investors will be pleased with their notable 57% return over the last yearJune 3, 2022 | finance.yahoo.comArecor's Sarah Howell discusses its recent webinar on the need for fast-acting insulinMay 31, 2022 | proactiveinvestors.comArecor’s CEO Sarah Howell previews key diabetes webinar on Thursday 26 MarchMay 24, 2022 | proactiveinvestors.comARECOR TO HOST KOL WEBINAR ON THE NEED FOR CONCENTRATED AND RAPID ACTING INSULIN TREATMENTS IN DIABETES CAREMay 18, 2022 | finance.yahoo.comArecor Therapeutics drug has the potential to be best-in-classApril 28, 2022 | proactiveinvestors.com.auArecor Therapeutics has strong pipeline of opportunities aheadApril 25, 2022 | proactiveinvestors.com.auArecor Announces Oral Presentation at Attd 2022 of Phase i Clinical Trial of At278 Ultra-Concentrated Ultra-Rapid Acting Insulin for DiabetesApril 12, 2022 | finance.yahoo.com Get Arecor Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AREC and its competitors with MarketBeat's FREE daily newsletter. Email Address AREC Media Mentions By Week AREC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AREC News Sentiment▼0.000.72▲Average Medical News Sentiment AREC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AREC Articles This Week▼00▲AREC Articles Average Week Get Arecor Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AREC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies e-therapeutics News SkinBioTherapeutics News Futura Medical News Sareum News OptiBiotix Health News Poolbeg Pharma News ImmuPharma News Synairgen News IXICO News Oxford BioDynamics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:AREC) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arecor Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Arecor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
